🔎 Trials Near Me

Beranda › Kanker Prostat › Kansas

Uji klinis Kanker Prostat di Kansas

22 studi untuk Kanker Prostat mencari peserta di lokasi di Kansas.

Kota di Kansas

Teks studi resmi (Bahasa Inggris)

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • HaysMed, Hays
  • Lawrence Memorial Hospital, Lawrence
  • The University of Kansas Cancer Center - Olathe, Olathe
  • dan 4 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 2 Okt 2026 · NCT06931340

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Central Care Cancer Center - Garden City, Garden City
  • Central Care Cancer Center - Great Bend, Great Bend
  • Veteran Administration Eastern Kansas Healthcare, Leavenworth
  • dan 4 lainnya
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

  • University of Kansas Cancer Center, Kansas City
  • The University of Kansas Cancer Center - Olathe, Olathe
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
  • dan 2 lainnya
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06632977

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • HaysMed, Hays
  • Lawrence Memorial Hospital, Lawrence
  • The University of Kansas Cancer Center - Olathe, Olathe
  • dan 4 lainnya
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT03866382

DESTINY-PANTUMOUR04

  • Research Site, Topeka
Menerima pesertaStudi observasional
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07124000

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

  • University of Kansas Hospital, Kansas City
Menerima pesertaFase 2/3
Usia 18 hingga 100 · Pria · Diperbarui 22 Sep 2026 · NCT06780670

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  • University of Kansas Medical Center, Westwood
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 22 Sep 2026 · NCT07213674

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

  • University of Kansas Hospital, Kansas City
Menerima pesertaFase 3
Usia 18 hingga 100 · Pria · Diperbarui 22 Sep 2026 · NCT06855277

A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer

  • University of Kansas Medical Center, Kansas City
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 15 Sep 2026 · NCT07581184

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

  • Wichita Urology Group, Wichita
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 11 Sep 2026 · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • University of Kansas Cancer Center, Kansas City
  • Lawrence Memorial Hospital, Lawrence
  • The University of Kansas Cancer Center - Olathe, Olathe
  • dan 3 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 10 Sep 2026 · NCT05946213

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

  • Kansas University Cancer Center, Kansas City
Menerima pesertaFase 2
Usia 18 ke atas · Pria · Diperbarui 24 Agu 2026 · NCT07745361

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

  • MidAmerica Cancer Care, Merriam
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 21 Agu 2026 · NCT04221542

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • Central Care Cancer Center - Garden City, Garden City
  • Mercy Hospital Pittsburg, Pittsburg
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 19 Agu 2026 · NCT04423211

HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer

  • University of Kansas Health System, Kansas City
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT03802851

Integrated Cancer Repository for Cancer Research

  • Saint Luke's Cancer Instititute - South, Overland Park
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 19 hingga 110 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT02012699

TERPS Trial for de Novo Oligometastic Prostate Cancer

  • KU Medical Center- Cancer Center, Kansas City
Menerima pesertaFase 2
Usia 18 ke atas · Pria · Diperbarui 3 Jun 2026 · NCT05223803

Study of AZD0754 in Participants With Metastatic Prostate Cancer

  • Research Site, Westwood
Menerima pesertaFase 1/2
Usia 18 hingga 130 · Pria · Diperbarui 23 Feb 2026 · NCT06267729

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

  • Wichita Urology Group, Wichita
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 4 Feb 2026 · NCT04729114

Vitamin D for Prostate Endocrine Therapy

  • University of Kansas Cancer Center, Kansas City
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Health System Saint Francis Campus, Topeka
  • dan 1 lainnya
Menerima pesertaFase 3
Usia 50 ke atas · Pria · Diperbarui 15 Jan 2026 · NCT05838716

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • University of Kansas Cancer Center, Kansas City
  • Olathe Health Cancer Center, Olathe
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • dan 1 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 11 Sep 2025 · NCT03678025

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.